Clinical trials
Withdrawn Phase 2 Insulinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academic and Community Cancer Research United | 1 |
| British Columbia Cancer Agency | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Montefiore Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulinoma | 4 |
| Gastrinoma | 3 |
| Carcinoma, Islet Cell | 2 |
| Glucagonoma | 2 |
| Somatostatinoma | 2 |
| Vipoma | 2 |
| Carcinoid Tumor | 1 |
| Congenital Hyperinsulinism | 1 |
| Hyperinsulinism | 1 |
| Neuroendocrine Tumors | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.